Drug services report negative effects from cannabis use

Of 22 services that replied to questions on products taken by service users, all reported herbal products (hash and weed), 12 services reported edibles, and 10 cited CBD (a non-psychoactive substance in cannabis, unlike THC). File picture

Seven out of ten drug services surveyed said their service users had experienced “significant negative health” effects from taking various cannabis-related products.

The Cannabinoid Market Survey, covering the first quarter of 2022, was conducted by the HSE National Social Inclusion Office and the National Voluntary Drug and Alcohol Sector.